(Q43116509)

English

Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats

scientific article published on 27 March 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

author name string

J-L Delongeas

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

G Vermeil de Conchard

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

A Beamonte

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

H Bertheux

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

C Spire

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

C Maisonneuve

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

N Becourt-Lhote

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

F Goldfain-Blanc

8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

N Claude

9

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

0 references

publication date

27 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Regulatory Toxicology and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

284-290

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Effect of vehicles on topical application of aloe vera and arnica montana components

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Experiments on the toxic, sedative and muscle relaxant potency of various drug solvents in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Chronic toxicity and oncogenicity studies of ethylene glycol in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Intranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

The possible role of endothelin(s) in cyclosporine A preparations--induced contraction of guinea pig isolated gallbladder strips

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Nonclinical vehicle use in studies by multiple routes in multiple species

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Species differences in the response to cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Ethylene glycol-mediated tubular injury: identification of critical metabolites and injury pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

The effects of drugs and chemicals upon the structure of the adrenal gland

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Adrenal gland: structure, function, and mechanisms of toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Different approaches for improving skin accumulation of topical corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

[Hormone replacement therapy: toxicity of glycol ethers]

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Gastro-intestinal patch system for the delivery of erythropoietin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Cyclosporine A preparations and their vehicles induce contraction of the guinea pig gallbladder in vitro: the role of cyclooxygenase metabolites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Effects of Labrasol on the corneal drug delivery of baicalin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.03.008

7 January 2021

Identifiers

10.1016/J.YRTPH.2010.03.008

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43116509&oldid=1981210606"